Literature DB >> 23620175

In brief: BRCA1 and BRCA2.

William D Foulkes1, Andrew Y Shuen.   

Abstract

The discovery of the first major breast cancer susceptibility gene, BRCA1, occurred almost 20 years ago. BRCA1, together with BRCA2 remain the most important discoveries in human cancer genetics. Identification of highly penetrant mutations in these two tumour suppressor genes has had broad implications for women at risk and their families, for health professionals caring for these persons and for basic researchers. The BRCA proteins have many critical functions, the most notable of which, from a clinical perspective, is repair of double-strand DNA breaks.
Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  DNA repair; PARP; breast cancer; cisplatinum; ovarian cancer; pathology; targeted therapy; triple negative

Mesh:

Substances:

Year:  2013        PMID: 23620175     DOI: 10.1002/path.4205

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  36 in total

1.  Scaling up to study brca2: the zeppelin zebrafish mutant reveals a role for brca2 in embryonic development of kidney mesoderm.

Authors:  Bridgette E Drummond; Rebecca A Wingert
Journal:  Cancer Cell Microenviron       Date:  2018-04-09

2.  Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.

Authors:  Axel Muendlein; Bettina H Rohde; Klaus Gasser; Anton Haid; Stephanie Rauch; Elena Kinz; Heinz Drexel; Wera Hofmann; Verena Schindler; Rita Kapoor; Thomas Decker; Alois H Lang
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-15       Impact factor: 4.553

Review 3.  'BRCAness' and its implications for platinum action in gynecologic cancer.

Authors:  Franco Muggia; Tamar Safra
Journal:  Anticancer Res       Date:  2014-02       Impact factor: 2.480

4.  Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair.

Authors:  Min Zhao; Dan-Dan Wang; Yuan Che; Meng-Qiu Wu; Qing-Ran Li; Chang Shao; Yun Wang; Li-Juan Cao; Guang-Ji Wang; Hai-Ping Hao
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

5.  Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.

Authors:  Li Li; Jinshan Zhang; Xin Weng; Ge Wen
Journal:  Tumour Biol       Date:  2014-09-19

6.  MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition.

Authors:  Xiaolin Liu; Ruifen Dong; Zhijun Jiang; Yuyan Wei; Yingwei Li; Linxuan Wei; Hengzi Sun; Yinuo Li; Ning Yang; Qifeng Yang; Zhaojian Liu; Beihua Kong
Journal:  Tumour Biol       Date:  2015-01-16

7.  miR-214-mediated downregulation of RNF8 induces chromosomal instability in ovarian cancer cells.

Authors:  Zheng Wang; Hao Yin; Yuanwei Zhang; Yukun Feng; Zhaofeng Yan; Xiaohua Jiang; Ihtisham Bukhari; Furhan Iqbal; Howard J Cooke; Qinghua Shi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Fertility preservation in reproductive-age women facing gonadotoxic treatments.

Authors:  J Roberts; R Ronn; N Tallon; H Holzer
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

9.  Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.

Authors:  Miriam Lobo; Sara López-Tarruella; Soledad Luque; Santiago Lizarraga; Carmen Flores-Sánchez; Oscar Bueno; Jesús Solera; Yolanda Jerez; Ricardo González Del Val; María Isabel Palomero; María Cebollero; Isabel Echavarría; Gabriela Torres; Miguel Martín; Iván Márquez-Rodas
Journal:  J Genet Couns       Date:  2017-12-15       Impact factor: 2.537

Review 10.  Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

Authors:  Carlos Andrés Ossa; Diana Torres
Journal:  Oncologist       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.